State Pharmacopoeia of Ukraine and Pharmaceutical Law: State Quality Standard for Medicines for Standardization and Quality Control During Circulation in Healthcare and Pharmacy Sectors

SSP Modern Pharmacy and Medicine, Journal Year: 2025, Volume and Issue: 5(1), P. 1 - 20

Published: Feb. 18, 2025

The organizational, legal, scientific, theoretical, expert, educational, methodological, and practical measures to support state standards for the quality, standardization, control of medicines during their circulation in healthcare pharmacy are comprehensively examined. quality requirements summarized, activities systematically categorized into organizational-legal, scientific-theoretical, areas. Proposals have been developed enhance increase effectiveness management system, while components external assessment professional testing programs carefully studied. Additionally, document outlines directions scientific-expert, normative activities, international cooperation, it explores collaborative agreements with scientific regulatory institutions, paving way innovative practices that further improve public health outcomes safety standards. Furthermore, research emphasizes importance cross-disciplinary approaches, integrating modern technological solutions data-driven strategies streamline processes ensure consistent adherence protocols. Stakeholder engagement, including input from professionals, pharmacists, researchers, is considered crucial identifying emerging challenges best within landscape. Strategic partnerships organizations reinforce a global commitment assurance, enabling comprehensive knowledge exchange harmonization These initiatives ultimately contribute robust framework safeguards health, fosters improvement pharmaceutical governance, enhances system resilience face challenges.

Language: Английский

---

The Potential of Vitamin D in Tuberculosis Pharmacotherapy: Retrospective, Marketing Review, and Application Prospects

SSP Modern Pharmacy and Medicine, Journal Year: 2025, Volume and Issue: 5(1), P. 1 - 15

Published: Jan. 21, 2025

This article thoroughly explores the importance of ergocalciferol, also known as vitamin D, in promoting overall human health, with particular emphasis on its role supporting tuberculosis treatment. Vitamin D is recognized for performing a variety critical functions: it fundamental maintaining strong bones, bolstering immune system, and contributing to healthy cardiovascular system. Based analysis presented, incorporating additional into multifaceted treatment regimen may result improved patient outcomes enhanced quality life. In addition discussing D’s health benefits, provides detailed examination market specialized foods fortified D. overview encompasses an array dosage forms, including capsules, tablets, other supplemental formats. Key manufacturing countries identified include United States, Poland, Germany, reflecting global nature supply chain. Among most prominent manufacturers Solgar, whose substantial share highlights wide range product options available consumers. ensures that individuals requiring can select from assortment brands formulations suit their specific needs. Moreover, underscores adhering established standards. By demonstrating compliance these guidelines, help build consumer trust reinforce reliability products marketplace. commitment ultimately benefits patients, enabling them confidently incorporate supplements healthcare routines.

Language: Английский

---

Modern Pulse Corticosteroid Therapy in Patients with Multiple Sclerosis: Adverse Events and Clinical and Pharmacological Measures to Eliminate Them

SSP Modern Pharmacy and Medicine, Journal Year: 2025, Volume and Issue: 5(1), P. 1 - 15

Published: Feb. 7, 2025

Pulse therapy with methylprednisolone remains the standard treatment for exacerbations of multiple sclerosis. The appointment corticosteroids can cause several undesirable phenomena and complications, one which is development steroid myopathy pronounced general weakness. To reduce expressiveness these violations, metacartin was used. study included 57 patients a reliable diagnosis sclerosis at stage exacerbation pathological process. There were 32 (56.14%) relapsing-remitting course sclerosis, 25 (43.85%) secondary-progressive course. All randomly divided into two groups: I – 33 (80.83%) who underwent pulse followed by introduction metacartin, II 24 (19.17%) received only therapy. Group 23 10 15 9 in group. showed effectiveness combination pulse-therapy prescription reliably reduced severity "muscular" symptoms when prescribed.

Language: Английский

---

Musculoskeletal Health Systematic Review: Clinical and Pharmacological, Organizational and Legal, Administration and Pharmaceutical Management Aspects

SSP Modern Pharmacy and Medicine, Journal Year: 2024, Volume and Issue: 4(2), P. 1 - 12

Published: April 1, 2024

This article examines current aspects of musculoskeletal health and pharmacotherapy disorders the human system. An objective review system was conducted in areas administration, clinical pharmacological, organizational legal, pharmaceutical management. The results systematic show that availability diagnoses section "Orthopedics traumatology" on platform state expert center Ministry Health Ukraine is limited. It necessary urgent to expand scientific base for practicing doctors. study confirmed importance using new protocols medical practice implementation evidence-based medicine pharmacy Ukraine. Gradual improvement allows increase quality, efficiency, safety, patients with paper guidelines developed basis evidence provided by Duodecim Medical Publications. shows a wide range treatment methods helps determine optimal therapy strategies field orthopedics. found non-steroidal anti-inflammatory drugs analgesics are more often prescribed system, which emphasizes perspective further legal researches development management drugs.

Language: Английский

---

Administration of Drugs for Pharmacotherapy of Tuberculosis According to GSP Requirements

SSP Modern Pharmacy and Medicine, Journal Year: 2024, Volume and Issue: 4(2), P. 1 - 17

Published: April 24, 2024

This research paper outlines the findings from a comprehensive investigation focused on dispensation and management of antituberculosis medications in pharmaceutical practices. The examination was conducted using various classification systems, including ATC codes, clinical pharmacological, legal, nomenclature legal groups. study provides detailed analysis harmonization process for GxP standards within Ukraine, offering thorough understanding current Additionally, looks into supply chain dynamics medication distribution. Developed are strategic guidelines proper storage these medications, essential maintaining their efficacy safety. A systematic proposal spatial organization facilities wholesale sector is presented, ensuring compliance with GSP. study’s goal to refine methodologies involved drugs, ultimate aim enhancing efficiency tuberculosis treatment protocols. This, turn, expected elevate caliber healthcare delivery care available patients afflicted tuberculosis. Expanding study's contributions, highlights implications public health policy potential streamline organization. By drawing attention criticality adherence rigorous protocols, underscores necessity meticulous oversight chain. insights gained not only pivotal providers but also policymakers tasked mandate curbing epidemic. proposed recommendations provide scaffold future enhancements drug

Language: Английский

---

Multidisciplinary Case Studies of Neuro-Oncology Disorders: Administration, Clinical and Pharmacological, Organizational and Legal, Pharmaceutical Management

SSP Modern Pharmacy and Medicine, Journal Year: 2024, Volume and Issue: 4(3), P. 1 - 11

Published: July 1, 2024

This article presents a series of multidisciplinary case studies on neuro-oncology disorders, encompassing aspects such as administration, clinical and pharmacological approaches, organizational legal frameworks, pharmaceutical management. A comprehensive plan has been developed for studying disorders amid comorbid conditions in the context military conflicts. The research outlines key directions, including scientific hypothesis, objectives, anticipated innovations, design, study subjects, methodologies, endpoints, evidence levels, descriptions technical products. Various facets project effectiveness are detailed, emphasizing discovery new correlations between conditions, paving way innovative therapeutic methods. design includes specific indicators treatment effectiveness, covering assessment, diagnosis, pharmacotherapy, psychosocial support, psychocorrection, strategies professional reintegration. degree is thoroughly evaluated. expected to yield highly credible results that will enhance optimization disorder treatments, improving medical, pharmaceutical, social, economic outcomes. By integrating these aims significantly advance understanding management particularly challenging environments conflict zones.

Language: Английский

---

ІНФУЗІЙНА ФАРМАКОТЕРАПІЯ ДЛЯ КОРЕКЦІЇ АКТИВНОСТІ АМІНОТРАНСФЕРАЗ У ПЛАЗМІ КРОВІ СЕРЕД ОНКОЛОГІЧНИХ ХВОРИХ ПІСЛЯ ПЕРЕДНЬОЇ РЕЗЕКЦІЇ ПРЯМОЇ КИШКИ У РАННЬОМУ ПІСЛЯОПЕРАЦІЙНОМУ ПЕРІОДІ

Actual Problems of Medicine and Pharmacy, Journal Year: 2024, Volume and Issue: 5(1), P. 1 - 14

Published: May 6, 2024

В сучасних умовах ВООЗ об’єднала зусилля у боротьбі з глобальним тягарем раку. Необхідно підвищення обізнаності в системі правовідносин «лікар-пацієнт-фармацевт». Підтримуюча фармакотерапія важлива для пацієнтів колоректальним раком. Для виявлення лікувальної дії інфузійного препарату Сорбілакт оперованих хворих на рак прямої кишки корекції активності амінотрансфераз плазмі крові обстежено дві групи онкологічних (основна і контрольна). Основній групі після передньої резекції ранньому післяопераційному періоді внутрішньовенно вводили інфузійний препарат дозі 600,0 мл добу швидкістю 30 крапель за хвилину протягом 5-ти днів. Контрольній - інфузійну терапію здійснювали 5% розчином глюкози 800,0 мл. Виявлено зростання аланін-амінотрансферази аспартат-амінотрансферази крові. при фармакотерапії препаратом Сорбілакт. Інфузійний рекомендується до широкого медичного застосування попередження післяопераційних ускладнень, особливо періоді.

---

Modern Classification of Respiratory Diseases: Innovations in the International Classification of Diseases of the 11th Revision

SSP Modern Pharmacy and Medicine, Journal Year: 2024, Volume and Issue: 4(4), P. 1 - 10

Published: Oct. 19, 2024

A comprehensive analysis has been performed on the innovations in classification of respiratory diseases introduced ICD-11, comparing it with previous ICD-10 version. This underscores critical importance implementing a more detailed and systematic approach to categorizing system. The enhancements found ICD-11 have proven open up new opportunities for timely high-quality provision medical pharmaceutical care. is particularly significant patients suffering from various injuries, including those resulting traffic accidents, participation combat operations, thoracic injuries. updated system allows precise diagnosis treatment plans, which essential improving patient outcomes. By providing granular level detail disease categorization, healthcare professionals can better understand nuances conditions. leads effective communication among doctors, pharmacists, patients, thereby legal professional relationships within Integrating into educational training programs advancing qualifications specialists. incorporating curricula development programs, practitioners stay abreast latest advancements integration also vital eliminating errors, as reduces likelihood misdiagnosis improper treatment. Furthermore, adopting supports ongoing sector Ukraine. It aligns country's practices international standards, facilitating collaboration global health organizations. alignment crucial enhancing overall quality services provided population. In conclusion, transition represents advancement diseases. Its implementation imperative care, specialist strengthening doctor-pharmacist-patient relationship. Embracing this will not only reduce errors but contribute further Ukraine's sector.

Language: Английский

---

Use Of Vitamins in Pharmacotherapy of Tuberculosis: Retrospective and Marketing Analysis

SSP Modern Pharmacy and Medicine, Journal Year: 2024, Volume and Issue: 4(4), P. 1 - 15

Published: Nov. 1, 2024

This paper explores the impact of antioxidant vitamins on prevention and pharmacotherapy tuberculosis. The author aims to assess potential advantages applications A, C, E in treating tuberculosis, especially among individuals at high risk Mycobacterium tuberculosis infection those with active disease. analysis indicates that these may offer significant benefits both preventing managing Known for their properties immune system support, are crucial combating infections. A marketing vitamin market Ukraine reveals availability popularity general population medical institutions. study provides valuable insights practice could serve as a foundation future research aimed improving prevention, diagnosis, treatment Moreover, incorporating into standard protocols enhance patient outcomes reduce disease burden. underscores necessity further clinical trials validate efficacy adjunct therapies. Understanding accessibility public perception aids designing effective health strategies. By emphasizing immunomodulatory effects, highlights role not only but also preventive healthcare measures against

Language: Английский

---

Bioresonance Therapy as an Innovative Method of Bioquantum Medicine

SSP Modern Pharmacy and Medicine, Journal Year: 2024, Volume and Issue: 4(4), P. 1 - 20

Published: Dec. 19, 2024

Bioresonance therapy is a cutting-edge approach that uses electromagnetic waves to restore the body’s natural bioelectric balance and activate inherent self-healing mechanisms. It steadily gaining recognition across diverse medical fields – ranging from allergology neurology metabolic disorders oncology. This article examines clinical outcomes associated with employing bioresonance for treatment support of various patient groups, including those allergies, autoimmune conditions (notably related Lyme disease), imbalances, chronic pain, depression, cancer, other health challenges. Of particular importance therapy’s demonstrated effectiveness in alleviating allergic reactions, stabilizing processes, managing neurological conditions, mitigating adverse effects conventional cancer treatments. Beyond these benefits, not only enhances patients’ overall well-being, but also complements traditional therapies by improving their outcomes, minimizing side effects, hastening recovery. has shown promise as means refine optimize existing regimens, thereby paving way more comprehensive care. The highlights method’s potential applications routine practice emphasizes necessity further trials identify optimal therapeutic parameters clarify its mechanisms action. could become crucial adjunct strategies, substantially quality life. As ongoing research continues elucidate role, incorporating into integrated plans may broaden horizons, enabling personalized, preventive, effective healthcare solutions future.

Language: Английский

---